Plus Therapeutics Inc (PSTV) — Cash Flow-to-Debt Ratio
Plus Therapeutics Inc (PSTV) has a Cash Flow-to-Debt Ratio of -0.83x as of June 2026, meaning its operating cash flow of $-7.13 Million could theoretically repay -1% of its total liabilities ($8.57 Million) in one year. See Plus Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Plus Therapeutics Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Plus Therapeutics Inc across 28 annual periods. For the full cash flow conversion analysis, see Plus Therapeutics Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Plus Therapeutics Inc (1998–2025)
Year-by-year debt coverage analysis for Plus Therapeutics Inc. Check cash flow quality index of Plus Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.69x | $-20.77 Million | $12.33 Million | ▼ -148.8% |
| 2024 | -0.68x | $-10.55 Million | $15.58 Million | ▲ +32.9% |
| 2023 | -1.01x | $-12.85 Million | $12.74 Million | ▼ -35.5% |
| 2022 | -0.74x | $-12.97 Million | $17.42 Million | ▲ +19.3% |
| 2021 | -0.92x | $-10.28 Million | $11.14 Million | ▲ +0.8% |
| 2020 | -0.93x | $-8.43 Million | $9.07 Million | ▼ -247.3% |
| 2019 | -0.27x | $-5.91 Million | $22.07 Million | ▲ +58.1% |
| 2018 | -0.64x | $-11.97 Million | $18.77 Million | ▲ +34.5% |
| 2017 | -0.97x | $-18.13 Million | $18.61 Million | ▼ -17.8% |
| 2016 | -0.83x | $-19.53 Million | $23.62 Million | ▼ -3.0% |
| 2015 | -0.80x | $-20.47 Million | $25.49 Million | ▼ -17.6% |
| 2014 | -0.68x | $-30.33 Million | $44.42 Million | ▲ +23.1% |
| 2013 | -0.89x | $-34.56 Million | $38.93 Million | ▼ -1.5% |
| 2012 | -0.87x | $-32.19 Million | $36.80 Million | ▼ -3.0% |
| 2011 | -0.85x | $-35.32 Million | $41.59 Million | ▼ -56.6% |
| 2010 | -0.54x | $-23.57 Million | $43.47 Million | ▲ +35.3% |
| 2009 | -0.84x | $-23.81 Million | $28.41 Million | ▲ +16.4% |
| 2008 | -1.00x | $-33.39 Million | $33.33 Million | ▼ -3.2% |
| 2007 | -0.97x | $-30.00 Million | $30.91 Million | ▼ -110.1% |
| 2006 | -0.46x | $-16.48 Million | $35.68 Million | ▼ -1343.1% |
| 2005 | -0.03x | $-1.10 Million | $34.40 Million | ▲ +96.8% |
| 2004 | -1.00x | $-12.57 Million | $12.64 Million | ▼ -81.0% |
| 2003 | -0.55x | $-7.25 Million | $13.18 Million | ▼ -6.4% |
| 2002 | -0.52x | $-6.89 Million | $13.32 Million | ▲ +71.1% |
| 2001 | -1.79x | $-8.32 Million | $4.66 Million | ▼ -75.8% |
| 2000 | -1.02x | $-2.98 Million | $2.93 Million | ▼ -133.3% |
| 1999 | -0.44x | $-5.11 Million | $11.72 Million | ▲ +73.9% |
| 1998 | -1.67x | $-1.52 Million | $912.00K | — |